Shaanxi Panlong Pharmaceutical Hits Day Low at CNY 31.16 Amid Price Pressure

Shaanxi Panlong Pharmaceutical Group has experienced a significant decline today, with the stock dropping by 7.82% as of March 23, 2026. The stock reached an intraday low of CNY 31.16, reflecting a challenging trading environment. Over the past week, the stock has decreased by 7.42%, and its performance over the last month shows a notable decline of 16.49%. In comparison, the China Shanghai Composite index has also faced downward pressure, declining by 3.63% today and 6.65% over the past week. Despite the recent downturn, Shaanxi Panlong has shown a year-to-date performance of 1.62%, contrasting with the broader index's negative return of 3.92%. Financial metrics indicate that the company has a market capitalization of CNY 1,858 million and a price-to-earnings ratio of 26.00. The return on equity stands at 7.14%, while the company maintains a dividend yield of 1.19%. These figures highlight the company's current market position within the pharmaceuticals and biotechnology sector, as it navigates through recent market fluctuations.